tradingkey.logo

Enovis Corp

ENOV
查看詳細走勢圖
26.840USD
+0.530+2.01%
收盤 12/24, 13:00美東報價延遲15分鐘
1.53B總市值
虧損本益比TTM

Enovis Corp

26.840
+0.530+2.01%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+2.01%

5天

-1.90%

1月

-9.32%

6月

-16.02%

今年開始到現在

-38.83%

1年

-38.93%

查看詳細走勢圖

TradingKey Enovis Corp股票評分

單位: USD 更新時間: 2025-12-24

操作建議

Enovis Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名43/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價48.11。中期看,股價處於下降通道。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Enovis Corp評分

相關信息

行業排名
43 / 206
全市場排名
117 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 10 分析師
買入
評級
48.111
目標均價
+79.79%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Enovis Corp亮點

亮點風險
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
業績高增長
公司營業收入穩步增長,連續3年增長34.84%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入2.11B美元
估值高估
公司最新PE估值-1.10,處於3年歷史高位
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉183.00股
活躍度降低
近期活躍度降低,過去20天平均換手率0.36

Enovis Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Enovis Corp簡介

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
公司代碼ENOV
公司Enovis Corp
CEOMcdonald (Damien)
網址https://www.enovis.com/

常見問題

Enovis Corp(ENOV)的當前股價是多少?

Enovis Corp(ENOV)的當前股價是 26.840。

Enovis Corp 的股票代碼是什麼?

Enovis Corp的股票代碼是ENOV。

Enovis Corp股票的52週最高點是多少?

Enovis Corp股票的52週最高點是49.380。

Enovis Corp股票的52週最低點是多少?

Enovis Corp股票的52週最低點是25.465。

Enovis Corp的市值是多少?

Enovis Corp的市值是1.53B。

Enovis Corp的淨利潤是多少?

Enovis Corp的淨利潤為-825.49M。

現在Enovis Corp(ENOV)的股票是買入、持有還是賣出?

根據分析師評級,Enovis Corp(ENOV)的總體評級為買入,目標價格為48.111。

Enovis Corp(ENOV)股票的每股收益(EPS TTM)是多少

Enovis Corp(ENOV)股票的每股收益(EPS TTM)是-24.355。
KeyAI